Theracurmin®
Colloidal submicron-particle curcumin exhibits high absorption efficiency-a double-blind, 3-way crossover study
Bioavailability
Learn More
Sunagawa Y, Hirano S, Katanasaka Y, Miyazaki Y, Funamoto M, Okamura N, et al.
J Nutr Sci Vitaminol (Tokyo). 2015;61(1):37-44. https://doi.org/10.3177/jnsv.61.37.
TC016
CLINICAL
Effect of endurance exercise training and curcumin intake on central arterial hemodynamics in postmenopausal women: pilot study.
Central Arterial Hemodynamics
Learn More
Sugawara J, Akazawa N, Miyaki A, Choi Y, Tanabe Y, Imai T, Maeda S.
Am J Hypertens. 2012 Jun; 25 (6): 651-656.
TC004
Clinical
Drinkable preparation of Theracurmin exhibits high absorption efficiency–a single-dose, double-blind, 4-way crossover study.
Bioavailability
Learn More
Morimoto T, Sunagawa Y, Katanasaka Y, Hirano S, Namiki M, Watanabe Y, Suzuki H, Doi O, Suzuki K, Yamauchi M, Yokoji T, Miyoshi-Morimoto E, Otsuka Y, Hamada T, Imaizumi A, Nonaka Y, Fuwa T, Teramoto T, Kakeya H, Wada H, Hasegawa K.
Biol Pharm Bull. 2013; 36 (11): 1708-1714.
TC011
Clinical
Short-term Effectiveness of Nexala® in the Treatment of Patients with Gonarthrosis and Coxarthrosis.
Knee Osteoarthritis
Learn More
Short-term Effectiveness of Nexala® in the Treatment of Patients with Gonarthrosis and Coxarthrosis.
Pablo M, Nestor Z, Jorge L.
Jpn Pharmacol Ther 2021 49; (2): 229–238.
TC045
Clinical
Innovative preparation of curcumin for improved oral bioavailability.
Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T.
Biol Pharm Bull. 2011; 34 (5): 660-665.
TC001
Pre-Clinical
Clinical
The Efficacy and Safety of Highly-Bioavailable Curcumin for Treating Knee Osteoarthritis: A 6-Month Open-Labeled Prospective Study.
Knee Osteoarthritis
Learn More
Nakagawa Y, Mukai S, Yamada S, Murata S, Yabumoto H, Maeda T, Akamatsu S.
Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 2020 13: 1–8.
doi: 10.1177/1179544120948471.
TC044
Clinical